Free Trial

Karyopharm Therapeutics (KPTI) Insider Trading & Ownership

→ Biden replacement revealed? (From Paradigm Press) (Ad)
Free KPTI Stock Alerts
$1.08
-0.02 (-1.38%)
(As of 03:34 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Karyopharm Therapeutics (NASDAQ:KPTI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.32%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$50,190.80
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$278,847.52
Get KPTI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Karyopharm Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

KPTI Insider Buying and Selling by Quarter

Ad Insider Financial
Thousands of investors use this no cost solution | Do you?
In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.
Simply tap here now to subscribe and start getting "Insider Financial Advantage"

Karyopharm Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/22/2024Reshma RangwalaEVPSell6,789$1.17$7,943.13  
4/4/2024Richard A PaulsonCEOSell3,563$1.29$4,596.27  
3/5/2024Richard A PaulsonCEOSell3,573$1.30$4,644.90  
2/29/2024Michael ManoSVPSell16,973$1.17$19,858.41  
2/29/2024Michael MasonCFOSell27,687$1.17$32,393.79  
2/29/2024Reshma RangwalaEVPSell15,667$1.17$18,330.39  
2/29/2024Richard A PaulsonCEOSell80,470$1.17$94,149.90  
2/27/2024Michael MasonCFOSell2,545$1.32$3,359.40  
2/15/2024Stuart PoultonEVPSell5,847$1.33$7,776.51  
2/6/2024Michael MasonCFOSell4,205$1.59$6,685.95  
2/6/2024Richard A PaulsonCEOSell4,012$1.59$6,379.08  
1/4/2024Richard A PaulsonCEOSell4,114$0.82$3,373.48  
12/4/2023Richard A PaulsonCEOSell3,622$0.79$2,861.38  
11/6/2023Richard A PaulsonCEOSell3,606$0.92$3,317.52  
10/4/2023Richard A PaulsonCEOSell3,589$1.27$4,558.03  
9/12/2023Garen G BohlinDirectorBuy41,140$1.22$50,190.80  
9/1/2023Michael ManoSVPSell3,888$1.33$5,171.04  
9/1/2023Michael MasonCFOSell6,913$1.33$9,194.29  
9/1/2023Sohanya Roshan ChengEVPSell7,415$1.33$9,861.95  
8/7/2023Richard A PaulsonCEOSell3,722$1.72$6,401.84  
7/28/2023Stuart PoultonEVPSell2,845$1.70$4,836.50  
7/5/2023Richard A PaulsonCEOSell3,538$1.72$6,085.36  
6/8/2023Sohanya Roshan ChengEVPSell1,839$2.35$4,321.65  
5/4/2023Richard A PaulsonCEOSell3,805$3.35$12,746.75  
(Data available from 1/1/2013 forward)

KPTI Insider Trading Activity - Frequently Asked Questions

Who is on Karyopharm Therapeutics's Insider Roster?

The list of insiders at Karyopharm Therapeutics includes Deepika Pakianathan, Garen G Bohlin, Jatin Shah, Michael Kauffman, Michael Mano, Michael Mason, Reshma Rangwala, Richard A Paulson, Sharon Shacham, Sohanya Roshan Cheng, Stephen Mitchener, and Stuart Poulton. Learn more on insiders at KPTI.

What percentage of Karyopharm Therapeutics stock is owned by insiders?

3.32% of Karyopharm Therapeutics stock is owned by insiders. Learn more on KPTI's insider holdings.

Which Karyopharm Therapeutics insiders have been buying company stock?

The following insider purchased KPTI shares in the last 24 months: Garen G Bohlin ($50,190.80).

How much insider buying is happening at Karyopharm Therapeutics?

Insiders have purchased a total of 41,140 KPTI shares in the last 24 months for a total of $50,190.80 bought.

Which Karyopharm Therapeutics insiders have been selling company stock?

The following insiders have sold KPTI shares in the last 24 months: Deepika Pakianathan ($2,126,692.50), Michael Mano ($25,029.45), Michael Mason ($89,214.62), Reshma Rangwala ($53,692.02), Richard A Paulson ($395,527.08), Sohanya Roshan Cheng ($56,318.48), Stephen Mitchener ($19,261.71), and Stuart Poulton ($31,335.12).

How much insider selling is happening at Karyopharm Therapeutics?

Insiders have sold a total of 655,982 Karyopharm Therapeutics shares in the last 24 months for a total of $2,797,070.98 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:KPTI) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
These AI trades triggered this morning (545% return)
Prosper Trading Academy
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative